Diclazuril is used in the prevention and treatment of equine protozoal myeloencephalitis (EPM) and other protozoan infestations in horses. The function of diclazuril is in attacking the chloroplast...
Equine protozoal myeloencephalitis (EPM) is a central nervous system (CNS) infection of horses with either of the apicomplexan protozoa Sarcocystis neurona or Neospora hughesi.1 EPM is a common...
Equine Protozoal Myeloencephalitis (EPM) is an extremely serious disease of horses which can be very difficult to diagnose because its signs often mimic other disorders and its signs can range from...
Diclazuril is a member of the triazine class of antiprotozoals. In the U.S., it is FDA-approved for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona and as a...
Equine protozoal myeloencephalitis (EPM) is a central nervous system (CNS) infection of horses with either of the apicomplexan protozoa Sarcocystis neurona or Neospora hughesi.1 EPM is a common...
Equine Protozoal Myeloencephalitis (EPM) is an extremely serious disease of horses which can be very difficult to diagnose because its signs often mimic other disorders and its signs can range from...
Diclazuril is a member of the triazine class of antiprotozoals. In the U.S., it is FDA-approved for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona and as a...
Equine Protozoal Myeloencephalitis (EPM) is an equine neurologic disease caused by the protozoan Sarcocystis neurona. The bacterium infects horses when they ingest the organism in feed or water that...
One of the most serious diseases of horses in the Americas is equine protozoal myeloencephalitis (EPM), a condition that affects the central nervous system. EPM is a disease of the brain and/or...
